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ventricular septum (n=l), right ventricular free wail (n=l) and coronary cusp (n=l). Acutely 
16/26 (62%) ablations were successful, 3i26 (12%) partially successful (arrhythmia 
became non sustained or there were other arrhythmias that were not targeted and 7/26 
(27%) unsuccessful. Three of the unsuccessful ablation sessions were repeated within 3- 
20 days. There were 3 complications (1 respiratory distress, 1 cardiac perforation and 1 
heart block). There was no recurrence at follow-up in 13/21 (62%) patients (mean follow up 
time 304.0±268.3 days). Time to recurrence (documented ventricular arrhythmia) in 8/21 
(38%) patients was 137±158 days. There were 2 deaths at 3 and 34 days (1 due to ventric- 
ular arrhythmia and 1 due to carebrovascular accident). 
CONCLUSION: Although infrequent catheter based ablation for ventricular tachycardia in 
patients with NIDCM is relatively safe and has good short and long term success rates. 
1063-138 Smoking Is Independently Associated With 
Cardiomegsly In Coronary and Non-Coronary  Deaths in 
Men 
Allen P. Burke, Andrew Farb, Robed Kutys, Renu Virmani, Armed Forces Institute of 
Pathology, Washington, Dist. of Columbia. 
Smoking and left ventricular hypertrophy are each independent risk factors for sudden car- 
diac death. Although coronary artery disease and hypertension are known to cause cardi- 
omegaly, an independent relationship between cigarette smoking and increased cardiac 
mass has not been documented, We studied 462 hearts at autopsy of men dying unexpect- 
edly due to severe coronary atherosclerosis (n=307, 52 ± 11 years old) and non cardiac 
causes (n=155, 42 ± 13 years o~d). Cases were selected prospectively, excluding genetic 
causes of cardiomegaly, idiopathic dilated cardiomyopathy, pure right-sided hyperlmphy, 
and valvular heart disease. Body weight, height, estimated body mass index (BMI, kg/m2), 
smoking (by history and corroborated by post-modem serum thiooyanate determination), 
diabetes (by history and blood glycohemoglobin determination), hypertension (by history 
and reel microvasculature assessment) and total cholesterol/high-density lipoprotein choles- 
terol ratio were determined at autopsy, as well as an estimate of coronary plaque burden 
(sum of maximal % luminal narrowing of 4 major epicardial arteries). By univariate analysis, 
smokers dying with severe coronary disease had increased BMI-adjusted heart weight 
(493¢f19 vs. 468±110 grams for non-smokers, p=.01), as well as control smokers (452 ± 
116 vs. 410 ± 76 grams for non-smokers, p=.01). By multivariate analysis in atherosclerotic 
deaths, smoking (p=.0003) was independently associated with increased heart weight, inde- 
pendent of body mass index (p=.0001), age (p=.0001), hypertension (p=.Ol), and plaque 
burden (p=.03); race, cholesterol, diabetes, and history of alcohol or drug abuse were not 
significantly associated with heart weight. Smoking was also independently associated with 
heart weight in controls (p=.009), independent of hypertension (p=.001), age (p=.001) and 
body mass index (p=.0001); other parameters were not significantly associated with heart 
weight. These results suggest that smoking is a risk factor for cardiomegaly, in addition to 
hypertension, obesity and coronary artery disease. The mechanism by which smoking 
increases the risk of sudden death may in part be mediated by ventticular hypertrophy. 
1063-139 Influence of Gender and Alcohol on Morta l i ty  in 
Non iechemic  Di lated Card iomyopathy  
Raiaa F. Faris, Michael Y Henein, Andrew JS Coats, The National Heart & Lung/nstitute, 
London, United Kingdom, Royal Brompton Hospital, United Kingdom. 
Background: Alcohol is a major cause of cardiomyopathy in Western Societies. in contrast 
to ischemic heart disease, little attention has been directed towards the identification of the 
effect of alcohol intake on mortality in patients with non-ischemic heart failure. 
Objectives: This study sought to examine the association between reported alcohol intake 
and subsequent cardiac mortality and whether the effect of alcohol is modified by gender in 
patients with non-ischemic dilated cardiomyopathy (DCM). 
Method and Results: Between 1994-1998, we retrospectively studied a cohort of 396 con- 
secutive patients with DCM, 74% men, mean age 53 ± 15 years. The history of alcohol 
intake was abstracted from the medical records. During a subsequent follow up period of 
48 ± 36 months, 53 (76% men) patients died and 15 (80% men) underwent cardiac trans- 
plantation. Men were younger and more likely to have a history of excessive alcohol intake 
compared to women. Gender significantly modified the risk of alcohol consumption on mor- 
tality. Whereas alcohol intake increased the mortality risk in women (hazard ratio for death 
(HR), 4.2, 95% confidence interval (CI), 1.4-9.3; p = 0.009), it was protective towards death 
in men (HR, 0.42, 95% CI, 0.37-1.0; p = 0.05). The effect of alcohol intake on outcome was 
reassessed again after classifying the patients into 4 groups: group 1 life-long non-drinkers, 
group 2 former drinkers, group 3 and 4 current drinkers. Moderate drinking was defined as 
<14units/week for women and <21 for men. Heavy drinking as >14 and >21 units a week, 
respectively for women and men. The 5-year survival rates for the groups among women 
and men were different; 90%, 90%, 63%, and 56%; p = 0.03 vs 67%, 90%, 80%, and 60%; 
p = 0.02. 
Conclusion: In our study, we have demonstrated that the risk of reported alcohol intake on 
mortality is related to gender in patients with non-ischemic heart failure. Although women 
live longer, they are more sensitive to the toxic effects of alcohol than men. Our findings 
deserve further prospective study as a possible way to improve outcome in such patients. 
1063-140 Ar rhythmlas  in Biopsy Proven Acute Myocard i t i s  
Versus Acute Pericarditis With No Evidence of 
Myocarditls in Endomyocardial Biopsy 
Arssn D. Ristic, Guenter Hufnagel, Sabine Pankuweit, Petar M. Seferovic, Miodrag 
Ostojic, Roland Moll, Bernhard Maisch, Department of Internal Medicine - Cardiology, 
and Department of Pathology Philipps-Universi~ Marburg, Germany, University Institute 
for Cardiovascular Diseases, Belgrade, Yugoslavia. 
Background: It is controversial whether the arrhythmias in acute pericarditts are of myo- 
cardial or pericardial origin, 
Methods: The aim of the study was to investigate the ECG changes, conduction, and 
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cardiac rhythm disorders in endomyocardial biopsy (EMB) proven acute myocarditis/per- 
imyocarditis (Group 1 :10  pts, 3/10 with perimyocarditis, 70% males, mean age 
46.1±15.8 years, mean heart rate (HR) 76.7±33.1 b/rain) in comparison to acute peri- 
carditis with no EMB evidence of myocarditis (Group 2:40 pts, 65% males, mean age 
45.6±15.7 years, mean HR 98.7±22.2 b/min). At the initial assessment all pts underwent 
echocardiography, cardiac catheterization, and biventricular EMB. Tissue samples were 
independently reviewed by two cardiac pathologists. Immunohistoohemistry and immu- 
nocytochemistry were performed, and only pts fulfilling Dallas and WHF criteria were 
selected for Group 1. 
Results: Comparative analysis of ECGs and 24h Hoiter recordings at initial presentation 
is shown in the table. Paroxysmal supraventricular tachyarrhythmias (PSVT), and ven- 
tricular fibrillation (VF) were significantly more frequent in myocarditis (one pt died and 2 
underwent ICD implantation) in contrast o atrial fibrillation (AF)(all p<0.05). 
Conclualon: In pts with EMB proven acute myocarditis,'perimyocarditis l fe threatening 
rhythm disorders occurred significantly more often than in pts with pericarditis with no 
EMB indications of m),ocarditis, which on the contrary had a hi~lher incidence of AF. 
(%) AF Low ST/l" AV Block AV Block PSVT VT VF 
Voltage Changes Gr. II Gr. lit 
Myocarditis(N=lO) 0* 30 30 0 10 40* 10 20* 
Pericarditis (N=40) 20 40 47.5 5 2.5 5 2.5 0 
1063-161 The Coxseckie-Adenovirus Receptor Is Associated With 
Dif ferent ia l  Suscept ib i l i ty  to  Group B Coxssckieviral 
Infection and Myocsrditis 
Anne Oeavskv. Tami Martino, Cathy Trinidad, Peter Liu, Heart & Stroke/Richard Lewar 
Centre of Excellence, U of Toronto, Toronto, Ontario, Canada, Toronto General Hospital, 
Toronto, Ontario, Canada. 
BACKGROUND: Group B coxsackieviruses (CVBs) are a common etiologic agent of viral 
myocarditis and dilated cardiomyopathy. The expression of specific viral receptors, such 
as the coxsackie-adenovirus receptor (CAR), may be the primary determinant of host 
susceptibility and organ tropism. 
METHODS: To explore CAR as a determinant of myocarditis susceptibility, the pathogen- 
esis of CVB3 infection was investigated in NJ and C57BL/6 mice, The organ distribution 
of murine CAR (mCAR) RNA and protein was compared between strains. In addition, 
mCAR was cloned and sequenced systematically to screen for mutations derived from 
murine tissues, cardiomyocytes and cell lines. 
RESULTS: Following CVB3 infection, sun/ival was similar between strains, but on histo- 
pathological examination, myocarditis was more severe in NJ mice. Using an RNA probe 
for CAR it was found that mCAR RNA expression was highest in liver, heart and kidney. 
Lower expression was detected in the pancreas, spleen and brain. CAR protein expres- 
sion was highest in the heads of the myocarditis-susceptible NJ mice. This is in associa- 
tion with increased CVB3 replication in A/J heads, Sequencing of cDNA clones from NJ 
myocytes and Vero cells led to the identification of a truncated CAR isoform, highly 
homologous between murine and monkey calls, The transmembrane and cytoplasmic 
regions of full length mCAR1 are replaced by a 24 amino acid segment at the C-terminal 
end of the protein. In addition, a recurring amino acid substitution in the first immunoglo- 
bulin loop (D1) of the extracallular portion of mCAR2 was identified. The ability of trun- 
cated CARs to mediate virus attachment was demonstrated by CVB3 binding assays. 
But, interestingly, productive infection was not observed. 
CONCLUSION: In conclusion, increased mCAR expression, and differential expression 
of receptor isoforms may play a role in susceptibility to CVB3 infection and myocarditis. 
1063-162 The Natural His tory  of  Restr ict ive Card iomyopsthy  
Presenting During Childhood 
Alan Nuaent. Piers Daubeney, Patty Chondros, Michael Cheung, Andrew Davis, John 
Cadin, Robed Weintraub, Royal Children's Hospital, Melbourne, Australia. 
Background: Restrictive cardiomyopathy (RCM) in children is associated with a poor 
prognosis. A better understanding of the natural history, especially the time to deteriora- 
tion, would facilitate management. 
Methods: The National Australian Childhood Cardiomyopathy Study is a population- 
based study of all children in Australia with primary cardiomyopathy (CM) who presented 
at 0-10 years of age between 1987-97. Diagnostic criteria was elevated filling pressures 
at cardiac catheterization and/or evidence of reduced diastolic ventricular volume with 
atrial enlargement on echccardiography, in the presence of normal ventricular wall thick- 
ness and preserved systolic function. Serial echocardiographic measurements were 
expressed as Z scores. Study end-points were death or transplantation. 
Results: There were 8 patients with RCM, representing only 2.5% of the study popula- 
tion. Half presented with congestive heart failure and the other half with progressive exer- 
cise intolerance. The median age at presentation was 3.05 years (range: 1.3-7.6) with at 
least 50% of all other CM types presenting less than 6 months of age (p=g.003). One 
child had a positive family history for CM and none had biochemical evidence of meta- 
bolic disease. All patients had biventricular restrictive physiology. From presentation 
there was a decline in mean left ventricular (LV) end diastolic dimension (Z score +0.22 
to -0.13) and mean LV fractional shortening (Z score +0.48 to -2.1), with an increase in 
mean LV posterior wall thickness (Z score -0.82 to +0.2). At latest follow-up 4 (50%) have 
died, 3 (38%) have undergone cardiac transplantation and 1 (12%) remains in chronic 
right heart failure. Freedom from death or transplantation was 75% at one year after pre- 
sentation and 38% at 5 years. The median time to death or transplantation was 2.39 
years (range 9 days-8.49 years). 
Conclueions: RCM presenting in children is rare, manifests with bivantricular involve- 
ment and presents at an older age compared to other CM types. Although the eventual 
outcome is poor, survival in this population-based study suggests that urgent cardiac 
transplantation is seldom required at the time of presentation. 
